Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Tuesday, June 9, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Grant Opportunities for June 1, 2015 through June 5, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Centers for Disease Control and Prevention (CDC)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

CDC: Educating State-level Stakeholders on Strategies to Address Winnable Battles in Public Health

Funding Opportunity Number: CDC-RFA-SO15-1501

The purpose of this project is to reduce the burden of leading causes of death and disability by providing capacity building assistance to states to address priority health issues. Using CDC’s Winnable Battle Initiative as a framework, the project is intended to help increase the uptake of interventions known to successfully address high burden health issues by helping decision makers prioritize issues to address, and educating them on the interventions with the best evidence to support them. This funding opportunity was announced on June 5, 2015. The application deadline is August 6, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

CDC: Improving Immunization Collaboration Among Pharmacists and Other Healthcare Providers

Funding Opportunity Number: CDC-RFA-IP15-1504PPHF15

The purpose of this Funding Opportunity Announcement (FOA) is to support collaboration among pharmacists and other healthcare providers in the context of providing immunizations. This funding opportunity was announced on June 6, 2015. The application deadline is July 27, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

USAMRAA: Duchenne Muscular Dystrophy Translational Leverage Award

Funding Opportunity Number: W81XWH-15-DMDRP-TLA

The Duchenne Muscular Dystrophy Translational Leverage Award supports leveraging existing human-based resources in translational research to address high-impact research ideas or unmet needs. Often, resources are not leveraged for maximum use beyond the original source and as a result, investigators expend time and money to duplicate those resources. This award supports translational research projects leveraging and/or querying existing repositories, registries, and/or clinical trials or clinical studies in order to conduct research. Projects may include, but are not limited to, drug and/or device development, novel interventions, resource refinement, database mining, and correlative studies. This funding opportunity was announced on June 4, 2015. The application deadline is October 21, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Duchenne Muscular Dystrophy Investigator-Initiated Research Award

Funding Opportunity Number: W81XWH-15-DMDRP-IIRA

The Duchenne Muscular Dystrophy (DMD) Investigator-Initiated Research Award (IIRA) supports translational research that will accelerate the movement of promising ideas in DMD into clinical applications. Translational research may be defined as an integration of basic science and clinical observations with the specific goal of developing new therapies. Although the ultimate goal of translational research is to move an observation forward into clinical application, translational research is most effective as a two-way continuum between the bench and the bedside. Within this continuum, the IIRA supports mid-stage or later translational research projects, including early-phase, proof-of-principle clinical trials and correlative studies to better inform the development of drugs, devices, and other interventions. Research projects may also include preclinical studies utilizing animal models, human subjects, or human anatomical substances. This funding opportunity was announced on June 4, 2015. The application deadline is October 21, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Duchenne Muscular Dystrophy Therapeutic Idea Award

Funding Opportunity Number: W81XWH-15-DMDRP-TIA

The Duchenne Muscular Dystrophy (DMD) Therapeutic Idea Award is designed to promote new ideas that are still in the early stages of development with the potential to yield high-impact data and new avenues of investigation for novel therapeutics for DMD treatment. This award supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in DMD therapeutics. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. Research that introduces a new paradigm, challenges current paradigms, introduces novel concepts or agents, or exhibits other uniquely creative qualities that may lead to potential therapies for DMD may be considered innovative. This funding opportunity was announced on June 4, 2015. The application deadline is October 21, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Spinal Cord Injury Clinical Trial Award

Funding Opportunity Number: W81XWH-15-SCIRP-CTA

The Spinal Cord Injury (SCI) Clinical Trial Award supports human subject research with the potential to have a major impact on the treatment or management of SCI and its consequences in military service members, Veterans, or other individuals. The SCI Clinical Trial Award encourages applications that specifically address one or more of the following areas: (1) pre-hospital, en-route care and early hospital management of SCI; (2) development, validation, and timing of promising interventions to address consequences of SCI and recovery improvement, including, but not limited to bladder, bowel, and autonomic dysfunction, cardiometabolic dysfunction, neuropathic pain and sensory dysfunction, pressure ulcers, respiratory dysfunction, and sexual dysfunction; and (3) identification and validation of best practices in SCI care including but not limited to critical care interventions, interventions for musculoskeletal health, rehabilitation interventions, surgical interventions, and psychosocial and behavioral interventions in military/Veteran populations. This funding opportunity was announced on June 2, 2015. The application deadline is October 14, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Spinal Cord Injury Translational Research Award

Funding Opportunity Number: W81XWH-15-SCIRP-TRA

The Spinal Cord Injury (SCI) Translational Research Award is intended to support translational research that will accelerate the movement of promising ideas in spinal cord injury research into clinical applications. Although not all inclusive, some examples include demonstration studies of pharmaceuticals and medical devices in preclinical systems, and/or clinical research on therapeutics, devices, or practice using human tissues or resources. Observations that drive a research idea may be derived from a laboratory discovery, population-based studies, or a clinician’s first-hand knowledge of patients and anecdotal data. The SCI Translational Research Award encourages applications that specifically address one or more of the following areas: (1) pre-hospital, en-route care and early hospital management of SCI; (2) development, validation, and timing of promising interventions to address consequences of SCI and recovery improvement, including, but not limited to bladder, bowel, and autonomic dysfunction, cardiometabolic dysfunction, neuropathic pain and sensory dysfunction, pressure ulcers, respiratory dysfunction, and sexual dysfunction; and (3) identification and validation of best practices in SCI care including but not limited to critical care interventions, interventions for musculoskeletal health, rehabilitation interventions, surgical interventions, and psychosocial and behavioral interventions in military/Veteran populations. This funding opportunity was announced on June 2, 2015. The application deadline is October 14, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Spinal Cord Injury Qualitative Research Award

Funding Opportunity Number: W81XWH-15-SCIRP-QRA

The purpose of the Spinal Cord Injury (SCI) Qualitative Research Award is to support qualitative research studies that will help researchers and clinicians better understand the experiences of individuals with SCI and thereby identify the most effective paths for adjusting to disability and/or improving overall quality of life, health, and functional status after SCI. This mechanism is specifically focused on military and Veteran populations in the years after SCI, examining the issues, barriers, and promoters of success for Service members during the transition from initial injury and acute care through rehabilitation and community reintegration; therefore, collaboration with military and VA researchers and clinicians is encouraged. Appropriate qualitative research topics include, but are not limited to, the explorative, descriptive, predictive, or explanatory study of the (1) barriers preventing Service members with SCI from returning to active duty, returning home, or reintegrating into the community, (2) impact of personal factors and co-morbid medical conditions that influence or mediate a patient’s health or quality of life during hospitalization following SCI, (3) impact of cultural values and beliefs on the success of rehabilitation and community reintegration, (4) impact of medical care decisions (e.g., choice of civilian, VA, or military facility, treatment type, etc.) on the success of rehabilitation and community reintegration, or the (5) impact of care provision on the spouse and/or families of the spinal cord injured, including career issues, emotional stress, physical strain and injury, intimacy, etc. This funding opportunity was announced on June 2, 2015. The application deadline is October 14, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Spinal Cord Injury Investigator-Initiated Research Award

Funding Opportunity Number: W81XWH-15-SCIRP-IIRA

The Spinal Cord Injury (SCI) Investigator-Initiated Research Award is intended to support studies that have the potential to make an important contribution to SCI research, patient care, and/or quality of life. The SCI Investigator-Initiated Research Award encourages applications that specifically address one or more of the following areas: (1) pre-hospital, en-route care and early hospital management of SCI; (2) development, validation, and timing of promising interventions to address consequences of SCI and recovery improvement, including, but not limited to bladder, bowel, and autonomic dysfunction, cardiometabolic dysfunction, neuropathic pain and sensory dysfunction, pressure ulcers, respiratory dysfunction, and sexual dysfunction; and (3) identification and validation of best practices in SCI care including but not limited to critical care interventions, interventions for musculoskeletal health, rehabilitation interventions, surgical interventions, and psychosocial and behavioral interventions in military/Veteran populations. This funding opportunity was announced on June 2, 2015. The application deadline is October 14, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

 

NIH Funding Opportunity Announcements:

 

NIH: Behavioral Epigenomics of Aging in Twin Studies

Funding Opportunity Number: RFA-AG-16-007

Twin research supported by the National Institute on Aging has transformed our understanding of behavior over the lifespan and allowed us to study the interplay of genetic and environmental factors that affect how we age, age-related changes in behavior, and behavioral concomitants of healthy aging, using primarily a quantitative genetic approach. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate progress in behavioral genomics and aging via the establishment of a twin-epigenomic network that will facilitate collaboration between existing twin studies of aging, including work on the harmonization of phenotypes and (epi)genotype collection procedures as well as the development of statistical methods for the analysis and meta-analysis of data sets including genomic, epigenomic, gene expression, and behavioral phenotypic data. This funding opportunity was announced on June 4, 2015. A letter of intent is due by December 14, 2015. The application deadline is January 14, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

 

NIH: NHGRI Genome Sequencing Program Analysis Centers

Funding Opportunity Number: RFA-HG-15-026

The National Human Genome Research Institute (NHGRI) seeks to establish Genome Sequencing Program Analysis Centers (GSPAC), which will undertake computational analyses of the data produced by the NHGRI Genome Sequencing Program (GSP) with the purpose of extracting genomic and biological knowledge. Specifically, the GSPACs will have two roles. First, they will undertake novel, investigator-initiated analyses that will cut across the individual projects and grants that are the primary data producing constituents of the overall GSP. These analyses may also use data generated by other large-scale genomics projects. GSPACs will develop improved or novel analyses and methods for all non-automated aspects of characterizing sequence variants in the data, after lower level data processing and variant calling. NHGRI has particular interest in questions about identifying associations between variants and disease phenotypes; analyses using existing functional data to leverage associations and/or make functional inferences; means to improve study design; and other higher level analyses. Second, the GSPACs will work together with the other GSP components on cross-program analyses that are directly relevant to goals defined in the Companion Funding Opportunities, which currently include defining the point at which a common disease/rare variant genome sequencing study is “comprehensive” or complete, and developing specifications for sample sets that could serve as common controls for common disease genome sequencing studies. This funding opportunity was announced on June 2, 2015. A letter of intent is due by July 25, 2015. The application deadline is August 25, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Early Medical/Surgical Subspecialists' Transition to Aging Research

Funding Opportunity Number: RFA-AG-16-015

The goal of this Funding Opportunity Announcement (FOA) is to provide support for early-stage physician-scientists, trained in medical or surgical specialties, to launch careers as future leaders in research on aging or in geriatrics. To achieve this goal, this FOA provides small grants to conduct transdisciplinary research on aging or in geriatrics research that will yield pilot data for subsequent aging- or geriatrics-focused research projects. As part of its focus on facilitating the development of early-stage physician-scientists who will become leaders in research on aging or in geriatrics, this FOA seeks to encourage the provision of supportive environments for candidates, and National Institute on Aging (NIA) will consider the extent to which a supportive environment is available to candidates. This funding opportunity was announced on June 2, 2015. A letter of intent is due by September 7, 2015. The application deadline is October 7, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Maximizing Investigators' Research Award for New and Early Stage Investigators

Funding Opportunity Number: RFA-GM-16-003

The Maximizing Investigators' Research Award (MIRA) seeks to provide support for all of the research in an investigator's laboratory that falls within the mission of the National Institute of General Medical Sciences (NIGMS). The purpose of this Funding Opportunity Announcement (FOA) is to test the feasibility of this grant mechanism for new and early stage investigators through a pilot program with restricted eligibility. It is anticipated  that the new mechanism will (1) increase the stability of funding for NIGMS-supported investigators, which could enhance their ability to take on ambitious scientific projects and approach problems more creatively, (2) increase flexibility for investigators to follow important new research directions as opportunities arise, rather than being bound to specific aims proposed in advance of the studies, (3) more widely distribute funding among the nation’s highly talented and promising investigators to increase overall scientific productivity and the chances for important breakthroughs, (4) reduce the time spent by researchers writing and reviewing grant applications, allowing them to spend more time conducting research, and (5) enable investigators to devote more time and energy to mentoring junior scientists in a more stable research environment. This funding opportunity was announced on June 2, 2015. A letter of intent is due by August 9, 2015. The application deadline is September 9, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

 

 

NIH: CTSA Network - Trial Innovation Centers

Funding Opportunity Number: RFA-TR-15-002

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to establish Trial Innovation Centers (TICs) for the Clinical and Translational Science Award (CTSA) Program.  Conducting multi-site clinical research in the U.S. is often associated with implementation delays and high costs that have led to the migration of many clinical trials elsewhere. This trend threatens U.S. competitiveness, reduces economic opportunities, and deprives U.S. patients of the option to participate in research.  The TICs will be lead centers of excellence in clinical trials and will facilitate the implementation of multi-site clinical studies by the CTSA Network. The TICs will transform the CTSA network’s ability to implement multi-site studies by adding innovative network capacity to the existing strength at the CTSA Hubs. The TICs will not be specific to one disease, but have the capacity to identify and coordinate a cadre of specialist investigators from across the CTSA network to implement studies efficiently in response to a broad range of disease specific opportunities. Select TICs, however, will have particular expertise to conduct multi-site studies with special populations, such as pediatric or geriatric subjects. This funding opportunity was announced on June 5, 2015. A letter of intent is due by August 15, 2015. The application deadline is September 15, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Understanding HIV Persistence in Infants

Funding Opportunity Number: PA-15-271

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research in the pathogenesis of perinatal HIV-1 infection by elucidating HIV-1 immune responses in the setting of the infant's evolving immune system and mechanisms of establishment and maintenance of HIV-1 latent viral reservoirs. Perinatal HIV-1 transmission remains a significant contributor to the HIV-1 epidemic. Despite progress in effective prevention strategies including provision of anti-retroviral therapy (ART) to pregnant women, more than 200,000 children continue to acquire HIV-1 annually. Infants account for roughly 10% of new HIV-1 infections globally but comprise less than 2% of the world’s population. Moreover, the decline in infant HIV-1 acquisition with implementation of wide-scale maternal-infant ART prophylaxis has not been as steep as predicted and efforts will not meet the World Health Organization’s goal to eliminate perinatal transmission by 2015. This funding opportunity was announced on June 5, 2015. The initial application deadline is September 7, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Harnessing Big Data to Halt HIV

Funding Opportunity Number: PA-15-273

The purpose of the Funding Opportunity Announcement (FOA) is to promote innovative research using Big Data Science (BDS) to understand the complex and substantially interrelated factors that place persons at risk of HIV infection and that influence their HIV treatment course. BDS approaches have the potential to bring together data on populations such that the epidemiology of risk and care can take into account the complexity of contextual factors in individual’s lives. Further, because this field is able to reveal unexpected correlations through analysis of diverse data, BDS approaches may reveal events that are rare, unseen in traditional datasets, and transient. Discovery and epidemiologic analysis of these events will considerably advance research on HIV networks of transmission and the care continuum. This funding opportunity was announced on June 5, 2015. The initial application deadline is September 7, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: High Quality Human and Non-Human Primate Genome Sequences

Funding Opportunity Number: RFA-HG-15-027

The National Human Genome Research Institute (NHGRI) seeks to fund efforts that will produce as a community resource very high quality reference genome sequence assemblies in the next three years for human (25-50 assemblies) and select non-human primates (10-12), as a complement to and improvement on existing assemblies. The availability of very high-quality human genome sequence assemblies would have a number of benefits. These include an improved ability to resolve structural variants and other structural features that are of high biomedical interest; the resolution of long-range haplotypes to allow understanding of gene and variant interactions based on real haplotypes, including long-range cis regulation; improve our ability to study genes and variants in structurally complex regions of the genome, and provide a more complete set of genes, including ones in heterochromatic regions. This funding opportunity was announced on June 2, 2015. A letter of intent is due by July 25, 2015. The application deadline is August 25, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Asthma and Allergic Diseases Cooperative Research Centers

Funding Opportunity Number: RFA-AI-15-032

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and basic research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies. This funding opportunity was announced on June 3, 2015. A letter of intent is due by September 2, 2015. The application deadline is October 2, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Dimensional Approaches to Research Classification in Psychiatric Disorders

Funding Opportunity Number: RFA-MH-16-510

This Funding Opportunity Announcement (FOA) seeks research grant applications designed to develop innovative ways of understanding mental disorders in clinical studies on the basis of experimental research criteria rather than traditional diagnostic categories. This FOA stems from the NIMH Research Domain Criteria (RDoC) project that is intended to further a long-range goal of contributing to diagnostic systems as informed by research on genetics, neuroscience, and behavior. The purpose of this FOA is to encourage applications to study mechanisms that may cut across multiple traditional diagnostic categories. Applications submitted in response to this FOA should be based upon RDoC criteria. Five organizing domains have been identified. These are Negative Valence Systems, Positive Valence Systems, Cognitive Systems, Social Process Systems, and Arousal/Regulatory Systems. Consensus workshops and guidance documents on these five domains have been completed and applications must focus on at least one of the constructs that have been defined in these RDoC workshops. This funding opportunity was announced on June 5, 2015. A letter of intent is due by September 9, 2015. The application deadline is October 9, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Prematurity-Related Ventilatory Control (Pre-Vent) Respiratory Outcomes Clinical Research Centers

Funding Opportunity Number: RFA-HL-16-015

The National Heart, Lung, and Blood Institute (NHLBI) invites applications from institutions willing to participate as a Clinical Research Center (CRC) for the Prematurity-Related Ventilatory Control (Pre-Vent) observational program under a cooperative agreement. The objective of the program is to investigate mechanisms of ventilatory control (e.g. chemoreceptor, mechanoreceptor, developmental, etc.) that contribute to instability of oxygenation and risk of morbidity and mortality in premature infants during and after the Neonatal Intensive Care Unit (NICU) using a prospective observational cohort. The ultimate goal is to gain greater insight into the pathogenesis of chronic respiratory disease of the premature, and discover targets for new prevention and treatment strategies to improve outcomes for very vulnerable children at the beginning of life. This funding opportunity was announced on June 5, 2015. A letter of intent is due by September 20, 2015. The application deadline is October 20, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Prematurity-Related Ventilatory Control (Pre-Vent) Respiratory Outcomes Leadership and Data Coordinating Center

Funding Opportunity Number: RFA-HL-16-016

The National Heart, Lung, and Blood Institute (NHLBI) invites applications from institutions willing to participate as the Leadership and Data Coordinating Center (LDCC) for the Prematurity-Related Ventilatory Control (Pre-Vent) observational program under a cooperative agreement. The objective of this program is to investigate mechanisms of ventilatory control (e.g. chemoreceptor, mechanoreceptor, developmental, etc.) that contribute to instability of oxygenation and risk of morbidity and mortality in premature infants during and after the Neonatal Intensive Care Unit (NICU) using a prospective observational cohort. This is an important step toward the identification of new opportunities for preventive interventions for high risk premature infants. This funding opportunity was announced on June 5, 2015. A letter of intent is due by September 20, 2015. The application deadline is October 20, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Exploiting RNA as a Target for HIV Interventions

Funding Opportunity Number: PA-15-272

The purpose of this Funding Opportunity Announcement (FOA) is to: (1) investigate the role of viral and cellular long non-coding RNAs (lncRNAs) in the regulation of HIV replication, pathogenesis, latency, immunity, and gene expression; (2) exploit lncRNAs for the development of novel HIV interventions; and (3) exploit advances in RNA structural biology to identify novel targets for HIV intervention and functional cure. Recent advances in RNA technologies have led to the discovery of non-coding RNAs (ncRNAs), which are divided into small ncRNAs and long ncRNAs (lncRNAs). Similarly, new RNA technologies and advances in RNA structural biology have opened up a wealth of opportunities for the discovery of new therapeutics that act by targeting RNA. Current gaps in HIV research include understanding the role of lncRNAs in the regulation of the HIV replication cycle and the discovery/development of agents that target HIV RNA structures as well as regulatory ncRNAs to diminish or abolish HIV replication. This FOA will focus on studies investigating the basic function of lncRNAs with regard to HIV replication and studies that target HIV RNA structures or HIV-regulating lncRNAs. This funding opportunity was announced on June 5, 2015. The initial application deadline is September 7, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Smoking Cessation within the Context of Lung Cancer Screening

Funding Opportunity Number: RFA-CA-15-011

The goal of this Funding Opportunity Announcement (FOA) is to improve the effectiveness and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening. The proposed projects must be aimed at determining: (1) the key components and characteristics of an effective smoking cessation intervention delivered in the LDCT setting; and/or (2) characteristics of an implementation strategy to optimally incorporate existing evidence-based smoking cessation intervention(s) into the LDCT setting. The projects must include prospective, comparative evaluation of the intervention(s) in terms of the rates of cessation and sustained abstinence (6-12 months after cessation) among current smokers undergoing screening. The LDCT screening site must be the essential context for the delivery of the cessation intervention, although interventions may also include services provided outside the site before or after screening. This funding opportunity was announced on June 5, 2015. A letter of intent is due by September 8, 2015. The application deadline is October 8, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Adherence Studies in Adolescents with Chronic Kidney or Urologic Diseases

Funding Opportunity Number: RFA-DK-15-017

Adherence to a prescribed treatment regimen, including medications, devices and behavioral recommendations, can significantly impact morbidity and mortality for patients with chronic diseases, including chronic kidney or urologic disease. When adherence to complex and seemingly rigid treatment regimens is poor, the results can be tragic. Adolescence is a particularly challenging time for adherence. There are few studies in pediatrics beyond the HIV literature that address non-adherence. The purpose of this Funding Opportunity Announcement (FOA) is to support research to improve adherence in adolescents with chronic kidney or urologic diseases. This FOA invites applications from new or established investigators to pursue research to better understand factors that influence adherence, develop appropriate measures of adherence, and test innovative strategies to enhance adherence in this vulnerable population. This funding opportunity was announced on June 5, 2015. A letter of intent is due by October 2, 2015. The application deadline is November 2, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Career Development Program in Emergency Care Research

Funding Opportunity Number: RFA-HL-16-019

This Funding Opportunity Announcement (FOA) encourages applications from organizations that propose creative and innovative institutional research career development programs in the mission area(s) of the sponsoring Institutes. In particular, this FOA invites applications to develop multidisciplinary clinical career development programs in emergency care research that prepare clinician-scientists for academic leadership roles and independent research careers in emergency medicine.  The goal of this FOA is to build a well-qualified cadre of emergency care investigators through an integrated, multidisciplinary mentored research and career development program by providing mentored research training to assist junior faculty in their transition into productive, independent clinician-scientists in areas related to emergency care research. This funding opportunity was announced on June 5, 2015. A letter of intent is due by September 9, 2015. The application deadline is October 9, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Partnerships for the Development of Host-Targeted Therapeutics to Limit Antimicrobial Resistance

Funding Opportunity Number: RFA-AI-15-024

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of candidate therapeutics that target host-encoded functions required for infection, replication, virulence, proliferation and/or pathogenesis of select bacterial pathogens for which drug resistance poses a significant public health concern. Antibacterial resistance is a global public health crisis. The combined impact of increasing resistance to current antibiotics and the limited pace of new antibiotic development threatens years of progress in fighting life-threatening bacterial infections and has led to increased morbidity, mortality and rising healthcare costs. Development of resistance is a natural outcome to treatment with therapeutics that directly kill or inhibit growth of targeted bacterial pathogens. Under this selective pressure, resistant bacteria have a significant advantage for expansion and dissemination, leading to the evolution of multi-drug resistant pathogens for which there are extremely limited or no treatment options. This funding opportunity was announced on June 5, 2015. A letter of intent is due by August 17, 2015. The application deadline is September 17, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement

Association Management Software Powered by YourMembership  ::  Legal